Immunology, Autoimmunity, IL-2 receptor, FOXP3 and T cell are her primary areas of study. Her Immunology research is multidisciplinary, relying on both Type 1 diabetes and Disease. The concepts of her Autoimmunity study are interwoven with issues in PTPN22, Function, B cell, Signal transduction and Phosphorylation.
She combines subjects such as Antigen-presenting cell, Molecular biology, T-cell receptor, Interleukin 2 and Cell biology with her study of IL-2 receptor. Her biological study spans a wide range of topics, including Regulatory T cell, Psoriasis, CD4 antigen and Pathogenesis. Her T cell study frequently draws connections between related disciplines such as Cytotoxic T cell.
Her primary areas of investigation include Immunology, Autoimmunity, T cell, Internal medicine and Antigen. Her Immunology and Rheumatoid arthritis, Immune system, FOXP3, IL-2 receptor and Autoantibody investigations all form part of her Immunology research activities. Her FOXP3 research is multidisciplinary, incorporating perspectives in Regulatory T cell, Cancer research, Cytokine and Cell biology.
Her IL-2 receptor study improves the overall literature in Cytotoxic T cell. Her Autoimmunity research includes elements of Autoimmune disease, Signal transduction, Type 1 diabetes and B cell. The T cell study combines topics in areas such as Epitope, Molecular biology and Major histocompatibility complex.
Jane H. Buckner mainly investigates Immunology, Rheumatoid arthritis, Internal medicine, Immune system and Disease. Her Immunology study frequently involves adjacent topics like Phenotype. Her Rheumatoid arthritis study incorporates themes from Autoantibody and Cohort.
Her work deals with themes such as Enhancer and Chromatin, Gene, Quantitative trait locus, which intersect with Immune system. Her Autoimmunity research incorporates elements of Systemic lupus erythematosus, Type 1 diabetes and Receptor. Her study in FOXP3 is interdisciplinary in nature, drawing from both IL-2 receptor, NOD mice and Genetic enhancement.
Her primary areas of study are Immune system, Immune tolerance, T cell, Immunology and Autoimmunity. Her research integrates issues of Phenotype, Enhancer, Colocalization and Effector in her study of Immune system. Her Phenotype study integrates concerns from other disciplines, such as Autoimmune disease, Transcription factor, Cell biology, Genome editing and FOXP3.
Her studies in T cell integrate themes in fields like Synovial Cell, Cell type, Natural killer cell and Synovial membrane. Her work carried out in the field of Immunology brings together such families of science as Systemic lupus erythematosus and Receptor. Her Autoimmunity study deals with the bigger picture of Disease.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4 + CD25 – T cells
Mindi R.Walker;Deborah J. Kasprowicz;Vivian H. Gersuk;Angéle Bènard.
Journal of Clinical Investigation (2003)
Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseases
Jane Hoyt Buckner.
Nature Reviews Immunology (2010)
Type 1 diabetes immunotherapy using polyclonal regulatory T cells.
Jeffrey A. Bluestone;Jane H. Buckner;Mark Fitch;Stephen E. Gitelman.
Science Translational Medicine (2015)
Complement receptor 2/CD21- human naive B cells contain mostly autoreactive unresponsive clones
Isabelle Isnardi;Yen Shing Ng;Laurence Menard;Greta Meyers.
Genetic Variation in PTPN22 Corresponds to Altered Function of T and B Lymphocytes
Mary Rieck;Adrian Arechiga;Suna Onengut-Gumuscu;Carla Greenbaum.
Journal of Immunology (2007)
The effector T cells of diabetic subjects are resistant to regulation via CD4+ FOXP3+ regulatory T cells.
Anya Schneider;Mary Rieck;Srinath Sanda;Catherine Pihoker.
Journal of Immunology (2008)
De novo generation of antigen-specific CD4+CD25+ regulatory T cells from human CD4+CD25- cells.
Mindi R. Walker;Bryan D. Carson;Gerald T. Nepom;Steven F. Ziegler.
Proceedings of the National Academy of Sciences of the United States of America (2005)
CD4+FOXP3+ T Regulatory Cells in Human Autoimmunity: More Than a Numbers Game
S. Alice Long;Jane H. Buckner.
Journal of Immunology (2011)
The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans
Laurence Menard;David Saadoun;Isabelle Isnardi;Yen Shing Ng.
Journal of Clinical Investigation (2011)
Defects in IL-2R Signaling Contribute to Diminished Maintenance of FOXP3 Expression in CD4+CD25+ Regulatory T-Cells of Type 1 Diabetic Subjects
S. Alice Long;Karen Cerosaletti;Paul L. Bollyky;Megan Tatum.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: